Key Insights

Highlights

Success Rate

70% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

17.6%

3 terminated out of 17 trials

Success Rate

70.0%

-16.5% vs benchmark

Late-Stage Pipeline

18%

3 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed with results

Key Signals

4 with results70% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (9)
P 2 (2)
P 3 (2)
P 4 (1)

Trial Status

Completed7
Unknown3
Terminated3
Not Yet Recruiting3
Withdrawn1

Trial Success Rate

70.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT04666155Not ApplicableCompleted

MOWOOT Device Treatment for Adults With Chronic Constipation

NCT07388589Not Yet Recruiting

Soluble and Osmotic Fibre (SOLOS) Diet for Constipation

NCT06319729Phase 2Not Yet RecruitingPrimary

A Chinese Herbal Medicine for IBS-C

NCT05941650Not ApplicableNot Yet Recruiting

To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome

NCT05757037Not ApplicableUnknownPrimary

Laser Acupuncture on Irritable Bowel Syndrome in Females

NCT05164861Not ApplicableCompleted

Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations

NCT05921383UnknownPrimary

Anorectal Manometry of Patients With Constipation Predominant IBS

NCT05321953Not ApplicableWithdrawn

The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation

NCT05392439Not ApplicableCompletedPrimary

Effect of taVNS on Abdominal Pain and Other Symptoms in Constipation-predominant Irritable Bowel Syndrome

NCT03336034TerminatedPrimary

Assessment of Responsiveness to Treatment by Experience Sampling Method

NCT05134584Phase 4Unknown

Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders

NCT03150212Not ApplicableCompletedPrimary

Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype

NCT00945334Not ApplicableCompletedPrimary

Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome

NCT00742872Phase 3TerminatedPrimary

Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome

NCT00912301Phase 2CompletedPrimary

Cheno Effect on Transit in Health and IBS-C

NCT01085643Not ApplicableCompletedPrimary

Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS)

NCT00607971Phase 3TerminatedPrimary

Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)

Showing all 17 trials

Research Network

Activity Timeline